Fundz

Who to call at Oncotelic Therapeutics, and when

Fundz watches for the moments Oncotelic Therapeutics starts buying, and tells you who to reach.

  • An alert the day Oncotelic Therapeutics raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Oncotelic Therapeutics, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Oncotelic Therapeutics. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Oncotelic Therapeutics Enters Joint Development Agreement with TechForce Robotics

Apr 02, 2026

Contract Type

joint_development_agreement

Agoura HillsBiotechnologyHealthcareHealth CareTherapeutics

Description

On March 31, 2026, Oncotelic Therapeutics, Inc. entered into a Joint Development, Manufacturing, and Licensing Agreement with TechForce Robotics, Inc. This agreement establishes a framework for the joint development and manufacturing of AI-enabled robotic systems for pharmaceutical environments. It includes a non-exclusive license of certain company intellectual property.

Quick answer

Oncotelic Therapeutics Enters Joint Development Agreement with TechForce Robotics (April 2, 2026). Oncotelic Therapeutics is based in Agoura Hills, California, United States.

What agreement did Oncotelic Therapeutics announce on April 2, 2026?
On March 31, 2026, Oncotelic Therapeutics, Inc. entered into a Joint Development, Manufacturing, and Licensing Agreement with TechForce Robotics, Inc. This agreement establishes a framework for the joint development and manufacturing of AI-enabled robotic systems for pharmaceutical environments. It includes a non-exclusive license of certain company intellectual property.
What does Oncotelic Therapeutics do?
Oncotelic Therapeutics, Inc. is focused on developing innovative therapies for cancer treatment, primarily through the use of immunotherapy.
Where is Oncotelic Therapeutics based?
Oncotelic Therapeutics is based in Agoura Hills, California, United States.

Source: Fundz verified event record.

Company Information

Company

Oncotelic Therapeutics

Location

Agoura Hills, California, United States

About

Oncotelic Therapeutics, Inc. is focused on developing innovative therapies for cancer treatment, primarily through the use of immunotherapy. The company's key products include novel therapeutic agents designed to enhance the immune response against tumor cells, with a particular emphasis on maximizing patient outcomes in oncology. Its operations are primarily based in the United States, with plans to explore global markets for its therapies. As a mid-sized biopharmaceutical company, Oncotelic is actively involved in clinical trials and research initiatives aimed at advancing its drug pipeline and expanding its therapeutic reach.

Related People

Vuong
Likely contact at this company
••••••••@••••••••

See Vuong's verified email →

Amit
Likely contact at this company
••••••••@••••••••

See Amit's verified email →

Saran
Senior decision-maker at this company
••••••••@••••••••

See Saran's verified email →

Create an account to reveal verified emails
Predictive Intelligence
Strategic

ML-powered predictions for Oncotelic Therapeutics's next move

Learn about Strategic plan

Oncotelic Therapeutics signed a new agreement. Fundz surfaces partnerships and contracts as they are announced.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.